News and Recent Work

Recent Work

Recent Work for Life Sciences

Series C Investment by MVM Partners LLP and Sofinnova Partners SAS in Neurent Medical Limited

17/FEB/2026

Byrne Wallace Shields LLP is pleased to have acted for MVM Partners LLP and Sofinnova Partners SAS i..

more info

PrioThera Series B Investment

03/FEB/2026

Byrne Wallace Shields LLP is pleased to have acted for our client, biotech company, PrioThera in rel..

more info

Sweepr

17/NOV/2023

Byrne Wallace Shields LLP advises Sweepr...

more info

Neuromod Devices Limited

13/APR/2023

Byrne Wallace Shields LLP advises Neuromod Devices Limited...

more info

ValitaCell

22/SEP/2022

Byrne Wallace Shields LLP advises ValitaCell...

more info

European Circular Bioeconomy Fund

04/JAN/2022

Byrne Wallace Shields LLP advises the European Circular Bioeconomy Fund (ECBF)...

more info

SEARCH RECENT WORK BY PRACTICE AREA
go
SEARCH RECENT WORK BY KEYWORD